Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

6,777 total articles

Arqit Quantum Inc. Announces Select Preliminary Financial Results for the First Half of Fiscal Year 2026

Arqit Quantum Inc. Announces Select Preliminary Financial Results for the First Half of Fiscal Year 2026

Arqit Quantum Inc. announced preliminary financial results for the first half of fiscal year 2026, showing revenue growth to approximately $620K-$630K compared to $67K in the prior year period. The increase reflects revenue recognition from existing and newly signed contracts. The company maintains a strong cash position of approximately $28.9 mill…

NeurAxis, Inc. Announces Preferred Stock Dividend

NeurAxis, Inc. Announces Preferred Stock Dividend

NeurAxis, Inc., a medical technology company specializing in neuromodulation therapies for chronic conditions, announced a stock dividend for holders of its Series B Preferred Stock. Shareholders of record on April 21, 2026 will receive common stock dividends payable on April 28, 2026, with approximately 510,605 shares expected to be issued. This m…

Garrett Motion to Hold First Quarter 2026 Financial Results Conference Call on Thursday April 30, 2026

Garrett Motion to Hold First Quarter 2026 Financial Results Conference Call on Thursday April 30, 2026

Garrett Motion Inc., a global leader in turbocharging and electrification technologies, announced it will release its first-quarter 2026 financial results on April 30, 2026, prior to U.S. market opening, followed by a conference call and webcast. The company highlights its ongoing commitment to innovation in automotive turbocharging, hydrogen fuel …

Opus Genetics Announces Data Presentations at the 2026 American Society of Cataract and Refractive Surgery Annual Meeting

Opus Genetics Announces Data Presentations at the 2026 American Society of Cataract and Refractive Surgery Annual Meeting

Opus Genetics announces presentations of three Phase 3 clinical trial data on its phentolamine ophthalmic solution at the 2026 ASCRS Annual Meeting, including full results from VEGA-3 for presbyopia, a post-hoc analysis of MIRA-2 for mydriasis reversal, and LYNX-2 for visual disturbances post-refractive surgery. The company highlights collaboration…

Beneficient Closes $8.75 Million GP Primary Capital Transaction

Beneficient Closes $8.75 Million GP Primary Capital Transaction

Beneficient (NASDAQ: BENF) announced the closing of an $8.75 million primary capital transaction with Quartus AI Fund LP, a fund investing in growth-stage Vertical AI ventures. The transaction provides Quartus with Convertible Preferred Stock in exchange for capital, increasing Beneficient's collateral for its ExAlt loan portfolio by approximately …

Wrap Lands Major Pre-Order for Over 20 Drone and Counter-Drone Systems, Advancing Expansion Across the U.K. and Europe

Wrap Lands Major Pre-Order for Over 20 Drone and Counter-Drone Systems, Advancing Expansion Across the U.K. and Europe

Wrap Technologies announced a purchase order from Advanced Blast & Ballistic Systems Group for 20 MERLIN-1 Counter-UAS drone systems targeting the UK public safety market. This order marks a key milestone in Wrap's international drone portfolio expansion and is a step toward broader adoption across the UK and Europe. The MERLIN-1 platform offers a …

SOLOWIN HOLDINGS Announces Participation in Libeara’s Funding Round to Accelerate Growth of the Tokenization Ecosystem

SOLOWIN HOLDINGS Announces Participation in Libeara’s Funding Round to Accelerate Growth of the Tokenization Ecosystem

SOLOWIN HOLDINGS (Nasdaq: AXG) through its venture arm AlloyX Ventures Limited has participated in a funding round for Libeara, a regulated real-world asset tokenization platform. This investment strengthens the collaboration between SOLOWIN and Libeara, advancing compliant digital infrastructure and broadening tokenization initiatives across Asia …

LiveOne (Nasdaq: LVO) Partners with Team Boxing League (TBL) to Stream 60+ Live Events Across 200+ Countries through June 12, 2026, Leading into the TBL Championship

LiveOne (Nasdaq: LVO) Partners with Team Boxing League (TBL) to Stream 60+ Live Events Across 200+ Countries through June 12, 2026, Leading into the TBL Championship

LiveOne, a Nasdaq-listed entertainment technology company, announced a strategic partnership with Team Boxing League to exclusively stream over 60 live boxing events globally through June 2026. The partnership leverages LiveOne's extensive global reach and live streaming expertise to expand its premium sports content portfolio, targeting new revenu…

Silicon Motion Announces First Quarter 2026 Earnings Conference Call

Silicon Motion Announces First Quarter 2026 Earnings Conference Call

Silicon Motion Technology Corporation announced it will release its Q1 2026 financial results on April 28, 2026, followed by a conference call on April 29. The company is a leading global supplier of NAND flash controllers for solid state storage devices across servers, PCs, smartphones, and IoT devices. The announcement includes detailed forward-l…

LifeMD® Now Offering Eli Lilly and Company’s Foundayo™ (orforglipron), a New GLP-1 Pill for Weight Management

LifeMD® Now Offering Eli Lilly and Company’s Foundayo™ (orforglipron), a New GLP-1 Pill for Weight Management

LifeMD, Inc. announces the addition of Eli Lilly's Foundayo (orforglipron), an FDA-approved oral GLP-1 medication for weight management, to its virtual care weight management program. Available through LillyDirect integration, Foundayo offers patients an affordable, once-daily pill to treat obesity and related conditions, complementing LifeMD's exi…

Ocean Power Technologies to Participate in Water Tower Research Insights Conference on April 15, 2026

Ocean Power Technologies to Participate in Water Tower Research Insights Conference on April 15, 2026

Ocean Power Technologies, a provider of clean maritime energy and robotics solutions, announced CEO Philipp Stratmann will participate in the Water Tower Research Insights Conference to discuss the company's strategy and growth outlook. The virtual event aims to connect investors with company leadership for insights into innovative businesses acros…

HomesToLife Announces Special Dividend of US$0.065 Per Share

HomesToLife Announces Special Dividend of US$0.065 Per Share

HomesToLife Ltd, a global furniture company listed on Nasdaq, announced a special cash dividend of $0.065 per share, totaling approximately $5.8 million. The dividend will be paid on April 30, 2026 to shareholders of record on April 22, 2026. The company operates across multiple continents with divisions in furniture export, leather trading, and di…

BiomX Acquires Zorronet, Autonomous AI Command-and-Control Platform for Real-Time Defense and Security Applications

BiomX Acquires Zorronet, Autonomous AI Command-and-Control Platform for Real-Time Defense and Security Applications

BiomX Inc. has completed the acquisition of Zorronet, an Israeli developer of AI-powered command-and-control software for real-time defense, security, and rescue applications. This strategic move marks BiomX's entry into the defense and security sectors and complements its existing interests in advanced detection technologies through DFSL. Zorronet…

FibroBiologics Presents Novel Thymus Organoid Platform to Combat Age-Related Immune Decline at Keystone Symposia on Aging and Immunity

FibroBiologics Presents Novel Thymus Organoid Platform to Combat Age-Related Immune Decline at Keystone Symposia on Aging and Immunity

FibroBiologics presented preclinical data showing their novel transplantable thymic organoid platform can restore thymic function, thereby reversing age-related immune decline. The organoids generated multiple functional T cell lineages, demonstrated diverse T cell receptor repertoires, and showed anti-tumor efficacy in mouse models. These findings…

NIO Inc. Files Its Annual Report on Form 20-F

NIO Inc. Files Its Annual Report on Form 20-F

NIO Inc., a leading global smart electric vehicle manufacturer, has filed its 2025 annual report on Form 20-F with the SEC. The report details the company's audited financials for the fiscal year ended December 31, 2025, and is available on NIO's investor relations website. The company reiterates its commitment to innovation and premium electric ve…

Cycurion Makes It Clear: Issues Litigation Hold Letters to 16 Market Makers as Company Aggressively Investigates Potential Harm to Shareholders

Cycurion Makes It Clear: Issues Litigation Hold Letters to 16 Market Makers as Company Aggressively Investigates Potential Harm to Shareholders

Cycurion, Inc., a Nasdaq-listed cybersecurity company, has issued litigation hold letters to 16 market makers as part of an ongoing investigation into potential stock price manipulation and short selling affecting its shares. The company is taking a strong legal stance to protect shareholder value while continuing its business growth and expansion …

Annovis Closes $10 Million Offering, Extending Cash Runway Through Phase 3 Alzheimer's Disease 6-Month NDA Submission

Annovis Closes $10 Million Offering, Extending Cash Runway Through Phase 3 Alzheimer's Disease 6-Month NDA Submission

Annovis Bio, a clinical-stage biotech focused on neurodegenerative diseases, completed a $10 million public offering alongside a $1.5 million insider investment, extending its cash runway through Q2 2027. This funding enables the company to advance its Phase 3 Alzheimer's disease trial of buntanetap, nearing full enrollment, with a 6-month symptoma…

Tenaris Convenes the Annual General Meeting of Shareholders and an Extraordinary General Meeting of Shareholders

Tenaris Convenes the Annual General Meeting of Shareholders and an Extraordinary General Meeting of Shareholders

Tenaris S.A., a global steel tube supplier to the energy sector, has scheduled its Annual General Meeting and Extraordinary General Meeting of Shareholders for May 12, 2026. The company has published all necessary documents related to these meetings, including agendas, reports, and proposed amendments, available on its and regulatory websites.

Replimune Receives Complete Response Letter from the FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma

Replimune Receives Complete Response Letter from the FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma

Replimune Group, Inc. announced receiving a Complete Response Letter from the FDA regarding its Biologics License Application for RP1 combined with nivolumab to treat advanced melanoma. The FDA did not approve the application citing concerns despite previous breakthrough therapy designation and positive trial results. The company expressed disappoi…